Dimensional Fund Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.8M Sell
2,216,653
-558,335
-20% -$7.81M 0.01% 1715
2026
Q1
$26.1M Sell
2,774,988
-312,806
-10% -$3.43M 0.01% 1844
2025
Q4
$38.4M Sell
3,087,794
-96,932
-3% -$1.29M 0.01% 1654
2025
Q3
$45.6M Buy
3,184,726
+267,134
+9% +$3.66M 0.01% 1573
2025
Q2
$35.8M Buy
2,917,592
+333,707
+13% +$4.85M 0.01% 1682
2025
Q1
$56.8M Buy
2,583,885
+212,160
+9% +$4.99M 0.01% 1395
2024
Q4
$53.8M Sell
2,371,725
-32,124
-1% -$701K 0.01% 1476
2024
Q3
$43.7M Buy
2,403,849
+618,840
+35% +$14.3M 0.01% 1582
2024
Q2
$52M Buy
1,785,009
+12,766
+0.7% +$379K 0.01% 1437
2024
Q1
$62.8M Buy
1,772,243
+157,131
+10% +$6.28M 0.02% 1301
2023
Q4
$70.3M Buy
1,615,112
+63,323
+4% +$2.49M 0.02% 1194
2023
Q3
$59.3M Buy
1,551,789
+112,426
+8% +$4.73M 0.02% 1226
2023
Q2
$59.2M Buy
1,439,363
+148,716
+12% +$7.16M 0.02% 1236
2023
Q1
$74.1M Buy
+1,290,647
New +$72.7M 0.03% 1032
2022
Q3
$54M Sell
1,274,934
-118,391
-8% -$6.07M 0.02% 1160
2022
Q2
$75.3M Buy
1,393,325
+13,289
+1% +$798K 0.03% 941
2022
Q1
$88.7M Buy
1,380,036
+23,877
+2% +$1.57M 0.03% 938
2021
Q4
$90.9M Buy
1,356,159
+31,192
+2% +$2.11M 0.03% 964
2021
Q3
$90.7M Buy
1,324,967
+155,011
+13% +$11M 0.03% 910
2021
Q2
$79.8M Buy
1,169,956
+163,838
+16% +$11.6M 0.03% 1041
2021
Q1
$69.5M Buy
1,006,118
+101,553
+11% +$6.88M 0.02% 1141
2020
Q4
$58.7M Buy
904,565
+22,722
+3% +$1.22M 0.02% 1232
2020
Q3
$41.6M Buy
881,843
+4,083
+0.5% +$194K 0.02% 1346
2020
Q2
$41.2M Buy
877,760
+32,403
+4% +$1.59M 0.02% 1367
2020
Q1
$37.8M Buy
845,357
+34,507
+4% +$1.81M 0.02% 1275
2019
Q4
$47.3M Sell
810,850
-49,331
-6% -$2.94M 0.02% 1496
2019
Q3
$51.7M Sell
860,181
-10,437
-1% -$622K 0.02% 1362
2019
Q2
$48.6M Buy
870,618
+85,436
+11% +$4.4M 0.02% 1453
2019
Q1
$43.8M Buy
785,182
+61,604
+9% +$3.14M 0.02% 1541
2018
Q4
$32.6M Sell
723,578
-36,168
-5% -$1.98M 0.01% 1662
2018
Q3
$50M Sell
759,746
-331,432
-30% -$20.6M 0.02% 1462
2018
Q2
$70.3M Sell
1,091,178
-358,727
-25% -$22.2M 0.03% 1015
2018
Q1
$80.2M Sell
1,449,905
-45,564
-3% -$2.39M 0.03% 808
2017
Q4
$71.6M Buy
1,495,469
+9,396
+0.6% +$460K 0.03% 917
2017
Q3
$75M Sell
1,486,073
-168,383
-10% -$8.65M 0.03% 824
2017
Q2
$90.2M Sell
1,654,456
-24,639
-1% -$1.18M 0.04% 602
2017
Q1
$70.7M Sell
1,679,095
-30,103
-2% -$1.29M 0.03% 790
2016
Q4
$73.3M Sell
1,709,198
-72,212
-4% -$2.94M 0.04% 715
2016
Q3
$73.5M Sell
1,781,410
-151,650
-8% -$6.35M 0.04% 655
2016
Q2
$77.1M Sell
1,933,060
-57,806
-3% -$2.08M 0.04% 567
2016
Q1
$67.1M Buy
1,990,866
+134,402
+7% +$4.19M 0.04% 631
2015
Q4
$62.9M Buy
1,856,464
+22,678
+1% +$709K 0.04% 652
2015
Q3
$54.6M Sell
1,833,786
-281,854
-13% -$8.81M 0.04% 722
2015
Q2
$58.3M Buy
2,115,640
+108,515
+5% +$2.89M 0.04% 721
2015
Q1
$50.6M Buy
2,007,125
+163,921
+9% +$3.87M 0.03% 820
2014
Q4
$40.9M Buy
1,843,204
+146,140
+9% +$2.96M 0.03% 966
2014
Q3
$34.4M Buy
1,697,064
+130,033
+8% +$2.59M 0.02% 1021
2014
Q2
$30.1M Buy
1,567,031
+220,099
+16% +$4.1M 0.02% 1198
2014
Q1
$25.3M Buy
1,346,932
+102,451
+8% +$1.98M 0.02% 1324
2013
Q4
$24.3M Buy
1,244,481
+163,610
+15% +$3M 0.02% 1328
2013
Q3
$17.8M Buy
1,080,871
+26,104
+2% +$419K 0.02% 1554
2013
Q2
$15.8M Buy
+1,054,767
New +$15.5M 0.01% 1564

Other funds holding IART

Dimensional Fund Advisors's IART Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Integra LifeSciences (IART) stake by 20% in Q2 2026, selling an estimated $7.81M and leaving 2,216,653 shares worth $39.8M. The position accounts for 0.01% of the portfolio, ranked #1715.

Dimensional Fund Advisors first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $90.9M in Q4 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Dimensional Fund Advisors held 2,216,653 shares of Integra LifeSciences worth $39.8M as of Q2 2026.
  • Dimensional Fund Advisors sold 558,335 Integra LifeSciences shares in Q2 2026, an estimated $7.81M.
  • Integra LifeSciences made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1715 holding.
  • Dimensional Fund Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's Integra LifeSciences position peaked at $90.9M in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.